AU1665499A - Formulation of a combination comprised of opioid and alpha adrenergic agonistsand the application thereof - Google Patents

Formulation of a combination comprised of opioid and alpha adrenergic agonistsand the application thereof

Info

Publication number
AU1665499A
AU1665499A AU16654/99A AU1665499A AU1665499A AU 1665499 A AU1665499 A AU 1665499A AU 16654/99 A AU16654/99 A AU 16654/99A AU 1665499 A AU1665499 A AU 1665499A AU 1665499 A AU1665499 A AU 1665499A
Authority
AU
Australia
Prior art keywords
agonistsand
opioid
formulation
application
alpha adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16654/99A
Other languages
English (en)
Inventor
Johannes Bartholomaus
Jurgen Betzing
Johanna Korioth
Johannes Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Chemie Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH, Chemie Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU1665499A publication Critical patent/AU1665499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16654/99A 1997-11-11 1998-11-02 Formulation of a combination comprised of opioid and alpha adrenergic agonistsand the application thereof Abandoned AU1665499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1997149724 DE19749724A1 (de) 1997-11-11 1997-11-11 Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln
DE19749724 1997-11-11
PCT/EP1998/006923 WO1999024023A2 (de) 1997-11-11 1998-11-02 FORMULIERUNG EINER KOMBINATION AUS OPIOID UND α-ADRENERGEM AGONISTEN UND DEREN VERWENDUNG

Publications (1)

Publication Number Publication Date
AU1665499A true AU1665499A (en) 1999-05-31

Family

ID=7848237

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16654/99A Abandoned AU1665499A (en) 1997-11-11 1998-11-02 Formulation of a combination comprised of opioid and alpha adrenergic agonistsand the application thereof

Country Status (5)

Country Link
AU (1) AU1665499A (de)
DE (2) DE19758564A1 (de)
PE (1) PE123899A1 (de)
WO (1) WO1999024023A2 (de)
ZA (1) ZA9810272B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1227807B1 (de) * 1998-10-20 2005-03-30 Omeros Corporation Spülende lösung und methoden zur hemmung von schmerzen und entzündungen
PE20001396A1 (es) * 1999-01-18 2000-12-23 Gruenenthal Chemie Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
PL354872A1 (en) * 1999-10-23 2004-03-08 Alkaloid Ad Oral dosage form comprising a salt of morphine or a morphine derivative
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
EP1942903A4 (de) * 2005-08-30 2011-01-12 Univ Kingston Potenzierung der therapeutischen wirkung eines opioid-rezeptor-agonisten und/oder hemmung oder umkehr der toleranz für opioid-rezeptor-agonisten mit einer ultraniedrigen dosis eines alpha-2-rezeptor-antagonisten
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
CA2677281C (en) * 2007-02-09 2019-10-29 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013090278A2 (en) 2011-12-11 2013-06-20 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
EP3150199B1 (de) 2012-05-02 2018-08-08 Orexo AB Neue alfentanilzusammensetzung zur behandlung von akutem schmerz

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation

Also Published As

Publication number Publication date
ZA9810272B (en) 1999-05-10
PE123899A1 (es) 1999-12-25
WO1999024023A2 (de) 1999-05-20
DE19758564A1 (de) 1999-08-26
WO1999024023A3 (de) 1999-07-15
DE19749724A1 (de) 1999-06-10

Similar Documents

Publication Publication Date Title
AU8127998A (en) Quinoline compounds and medicinal uses thereof
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU6452896A (en) Rotary sprinkler and base
AU1665499A (en) Formulation of a combination comprised of opioid and alpha adrenergic agonistsand the application thereof
AU9781998A (en) Huchordin and uses thereof
ZA985096B (en) Composition compound and use
AU4266596A (en) Composition and use
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU1145899A (en) Benzyl-biphenyls and analogous compounds and the application thereof in order totreat arteriosclerosis and dyslipidaemia
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU8695298A (en) Compounds and uses thereof
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU6519198A (en) Melaninization inhibitor, skin-care preparation, and bath agent
AU5531798A (en) Pharmacologically active compounds and use
AU7681498A (en) Pharmaceutical composition and use thereof
AU3116697A (en) Human interleukin-1j and antagonists thereof
AU1846397A (en) Prolactin antagonists and uses thereof
AU2454899A (en) A surface covering backing containing polymeric microspheres and processes of making the same
AU6955898A (en) Retinoid antagonists and uses thereof
AU9630398A (en) A building and use thereof
AU9457798A (en) Chromone compounds and use thereof
PL341293A1 (en) Beta-lypothropin and application thereof
PL325270A1 (en) Coating compound and application thereof
AU8693198A (en) Compounds and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase